Pharmacosmos launches cell therapy market offensive

After launching a new product for freezing down for example stem cells, Pharmacosmos aims to become a leading supplier for the growing number of companies working with cell therapy.

Photo: Pharmacosmos / PR

Usually, all eyes are on the Pharmacosmos business leg which develops treatments for people - for example, those suffering from anemia.

Now, however, one of its other business legs is taking a big step forward, as the company has launched a product targeting cells, which will make it a serious player in the cell therapy area.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs